Results 61 to 70 of about 17,990 (185)
Brazilian Journal of Biology, 2018 Zoonotic visceral leishmaniasis (ZVL), caused by protozoans of the genus Leishmania, it is a worldwide of great importance disease. In the northeast region of Brazil, the state of Alagoas has an endemic status for ZVL.
M. A. N. Rocha +3 more
doaj +1 more source
Advanced Science, Volume 12, Issue 33, September 4, 2025.This review comprehensively examines the applications of protein three‐dimensional structures and artificial intelligence in investigating drug synergistic and antagonistic effects. The research findings provide compelling evidence for the precision treatment of cancer and metabolic diseases, thereby promoting the development of personalized medicine ...
Anqi Lin +11 more
wiley +1 more source
BMC Research Notes, 2018 Objective Based on studies in India (as there was no studies from outside India) amphotericin B deoxycholate has been considered as a backup drug for treatment of visceral leishmaniasis.
Md Golam Hasnain +7 more
doaj +1 more source
Antileishmanial Activities of Carvacrol Nanoencapsulate in Biopolymeric Nanoparticles
Chemistry &Biodiversity, Volume 22, Issue 9, September 2025.The study obtained biopolymeric nanoparticles containing carvacrol (NPCar) and evaluated their anti‐leishmanial activity. NPCar obtained presented physicochemical characteristics due to its ideal nanometric size and zeta potential, and low polydispersity index.
Joyce Cordeiro Borges +6 more
wiley +1 more source
Therapeutic Options for Visceral Leishmaniasis [PDF]
Drugs, 2013 Visceral leishmaniasis (VL), also known as Kala-Azar, is a disseminated protozoal infection caused principally by Leishmania donovani and Leishmania infantum (known as Leishmania chagasi in South America). The therapeutic options for VL are diverse and depend on different factors, such as the geographical area of the infection, development of ...
Begoña Monge-Maillo +1 more
openaire +3 more sources
Health Science Reports, Volume 8, Issue 9, September 2025.ABSTRACT Background and Aims Cutaneous leishmaniasis (CL) represents the most common form of leishmaniasis. It imposes a significant medical burden due to long‐lasting ulcers and disfiguring scars, underscoring the need for comprehensive CL control strategies, particularly in endemic regions.
Bahareh Abtahi‐Naeini +5 more
wiley +1 more source
Public Health Challenges, Volume 4, Issue 3, September 2025.ABSTRACT Background and Aim Mathematical modelling plays an important role in public health by enabling the prediction of disease outbreaks, assessment of transmission dynamics and evaluation of intervention strategies. Although widely applied in high‐resource settings, its use in underserved contexts remains underexplored. This review aimed to examine
Mavhunga Khumbudzo +3 more
wiley +1 more source
Interventions for visceral leishmaniasis
Cochrane Database of Systematic Reviews, 2010 Reason for withdrawal from publication This protocol is being withdrawn from The Cochrane Library. The authors have made no progress with this protocol in seven years. The protocol is out of date and does not meet the current methodological standards of Cochrane.
Urbà González +6 more
openaire +3 more sources
Revista MVZ Córdoba, 2000 La leishmaniasis visceral canina (LVC), producida por Leishmania infantum (=Leishmania chagasi) es una patología infecciosa zoonótica de importancia para la salud pública en países del Nuevo y Viejo Mundo. En Colombia se la encuentra distribuida en varios focos donde predomina el bosque seco tropical (Corredor et al., 1989).
openaire +4 more sources